Search company, investor...

Predict your next investment

Point72 Asset Management company logo
Family Office
point72.com

Investments

45

Portfolio Exits

21

Funds

3

About Point72 Asset Management

Point72 Asset Management operates as a family office managing the assets of its founder, Steven A. Cohen, and certain eligible employees. It focuses primarily on discretionary long or short equity investing and makes quantitative and macro investments. It was formerly known as SAC Capital Advisors and changed its name to Point72 Asset Management. The firm was founded in 1992 and is based in Stamford, Connecticut.

Headquarters Location

72 Cummings Point Road

Stamford, Connecticut, 06902,

United States

203-890-2000

Want to inform investors similar to Point72 Asset Management about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Point72 Asset Management News

Point72 Asset Management & Steve Cohen make a bold move with an 18.95M share acquisition in Cybin Inc.

Sep 18, 2023

Opinions expressed by Digital Journal contributors are their own. In a groundbreaking move that signals institutional interest in the burgeoning field of psychedelics, Point72 Asset Management and its founder, billionaire investor Steve Cohen, have acquired 18.95 million beneficially owned shares of Cybin Inc. ( NYSEAMERICAN: CYBN ). The announcement came via an SEC Schedule 13G form, which is filed when a party’s ownership of stock exceeds 5% of a company’s total stock issue. The filing also revealed that Point72 Asset Management now holds an impressive portfolio value of $33.62 billion, underlining its significant influence in the investment world. Image courtesy Point72 Asset Management The Psychedelic Frontier Cybin Inc. is at the forefront of the rapidly expanding psychedelics industry, focusing on developing therapies that leverage psychedelic substances to treat mental health disorders such as depression, anxiety, and PTSD. The move by Point72 and Steve Cohen signifies not just a bet on Cybin, but a high-profile endorsement of the entire psychedelics sector. What This Means for Cybin The acquisition of nearly 19 million shares by a behemoth like Point72 brings significant attention and credibility to Cybin. As institutional investors typically conduct meticulous due diligence before taking such large positions, Point72’s investment can be seen as a significant vote of confidence in Cybin’s future prospects. A Calculated Risk It’s no secret that the field of psychedelics carries with it an array of uncertainties, from regulatory hurdles to the stigma attached to psychedelic substances. However, initial studies have shown promising results in using psychedelics for medical treatment, and public sentiment seems to be gradually shifting. Cohen and Point72 seem to be calculating that the risk will yield high returns in the long run. Photo courtesy Point72 Asset Management Industry Ramifications Point72’s investment could serve as a catalyst for more institutional money to flow into the psychedelics sector. Already, various startups and established companies are working on medical applications for psychedelic substances, from microdosing LSD for treating depression to using psilocybin—the active compound in magic mushrooms—for anxiety relief. Cohen and Point72 joining the fray could be a sign that the industry is maturing and becoming increasingly attractive to major investors. Looking Ahead While the regulatory landscape for psychedelics remains a wild card, the investment by Point72 and Steve Cohen seems to herald a pivotal moment for the industry. As one of the most significant endorsements to date, this could trigger a chain reaction that leads to more capital, research, and ultimately, mainstream acceptance of psychedelics as a viable treatment for mental health disorders. For an industry that has long been on the fringes of medical science, the move by Point72 and Steve Cohen could be the nudge it needs to step into the spotlight. Disclosure: The information presented in this article is based on public records and should not be considered financial advice.

Point72 Asset Management Investments

45 Investments

Point72 Asset Management has made 45 investments. Their latest investment was in MediWound as part of their PIPE - II on February 2, 2023.

CBI Logo

Point72 Asset Management Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/5/2023

PIPE - II

MediWound

$27.5M

Yes

2

9/27/2022

Series D

Unravel

$50M

Yes

3

8/10/2022

Series C

Boulevard

$70M

Yes

8

1/5/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

9/14/2021

Seed

Subscribe to see more

Subscribe to see more

10

Date

2/5/2023

9/27/2022

8/10/2022

1/5/2022

9/14/2021

Round

PIPE - II

Series D

Series C

Series B

Seed

Company

MediWound

Unravel

Boulevard

Subscribe to see more

Subscribe to see more

Amount

$27.5M

$50M

$70M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

3

8

10

10

Point72 Asset Management Portfolio Exits

21 Portfolio Exits

Point72 Asset Management has 21 portfolio exits. Their latest portfolio exit was Korro Bio on July 14, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/14/2023

Acq - Pending

$99M

3

8/2/2022

Shareholder Liquidity

$99M

1

3/12/2021

IPO

$99M

Public

1

4/25/2018

Acq - P2P

Subscribe to see more

$99M

Subscribe to see more

10

11/15/2017

Acq - P2P

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/14/2023

8/2/2022

3/12/2021

4/25/2018

11/15/2017

Exit

Acq - Pending

Shareholder Liquidity

IPO

Acq - P2P

Acq - P2P

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

3

1

1

10

10

Point72 Asset Management Acquisitions

3 Acquisitions

Point72 Asset Management acquired 3 companies. Their latest acquisition was Neways Enterprises on January 20, 2012.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/20/2012

Debt

$99M

Acq - Fin - II

4/9/2010

Series C

Subscribe to see more

$99M

$99M

Subscribe to see more

10

8/18/2007

Private Equity

Subscribe to see more

$99M

$99M

Subscribe to see more

0

Date

1/20/2012

4/9/2010

8/18/2007

Investment Stage

Debt

Series C

Private Equity

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Total Funding

$99M

$99M

Note

Acq - Fin - II

Subscribe to see more

Subscribe to see more

Sources

10

0

Point72 Asset Management Fund History

3 Fund Histories

Point72 Asset Management has 3 funds, including Point72 Private Equity Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

11/16/2021

Point72 Private Equity Fund

$600M

1

Point72 Select

$99M

10

Altere Capital

10

Closing Date

11/16/2021

Fund

Point72 Private Equity Fund

Point72 Select

Altere Capital

Fund Type

Status

Amount

$600M

$99M

Sources

1

10

10

Point72 Asset Management Team

22 Team Members

Point72 Asset Management has 22 team members, including current Chief Information Officer, Seetharam Gorre.

Name

Work History

Title

Status

Seetharam Gorre

Chief Information Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Seetharam Gorre

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Chief Information Officer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.